Dr. Ahmed Farhan
If you’ve spent any time reading about diabetes or weight, you’ve heard that insulin resistance is bad news. It’s usually described as an early warning sign — a step on the road to type 2 diabetes, heart disease, and other problems.
But a new study is complicating that story. Researchers found a group of people who have a lifelong, genetic form of insulin resistance — and it doesn’t seem to be hurting them at all. In fact, some of them may be a little healthier because of it.
This doesn’t mean insulin resistance is suddenly something to welcome. But it does mean the story is more interesting, and more useful, than “insulin resistance equals danger.” Here’s what the researchers found, what it means, and what it doesn’t mean.
Why This Is Getting Attention Right Now
The study comes from a team at the University of Exeter in the United Kingdom, led by researcher Jacques Murray Leech and Associate Professor Kashyap Patel.
It will be presented at the Annual Meeting of the European Association for the Study of Diabetes in Milan, Italy, at the end of September 2026.
That timing matters for one important reason: this is still preliminary research. It hasn’t gone through full peer review and publication in a scientific journal yet.
It’s being shared at a major medical conference, which is a normal and legitimate way for scientists to present early findings — but it also means the results should be treated as promising, not settled.
Even with that caveat, the topic has caught attention because it challenges something a lot of people think they understand.
Insulin resistance is usually talked about as a single, simple problem. This study suggests it might actually be several different things happening in the body, some more harmful than others.
What the Researchers Actually Did
The team used a massive resource called the UK Biobank, which stores genetic and health information from hundreds of thousands of volunteers. They looked at whole-genome data from 458,784 people of European ancestry.
Inside that huge group, they searched for something rare: people carrying a damaged version of a gene called INSR.
This gene contains the instructions for building the insulin receptor — the “docking station” on the surface of cells that insulin has to plug into for its message to get through.
They found 524 people carrying one of these damaged INSR gene copies. Because everyone carries two copies of most genes, having one damaged copy still leaves the other copy working.
That’s why these people are healthy enough to be part of a general population study, rather than having a severe, rare disorder.
Because this insulin receptor problem is present from birth and isn’t caused by extra body fat, it gave the researchers a rare chance to study insulin resistance in its “purest” form — separate from the excess weight that usually comes along with it in the real world.
What Researchers Found
The 524 gene-variant carriers showed a classic sign of insulin resistance: mildly high insulin levels in their blood relative to their blood sugar. This is called hyperinsulinemia, and it’s usually treated as a warning flag.
But when the researchers compared these carriers to everyone else in the study, the warning flag didn’t seem to predict trouble. The carriers did not show a higher risk of:
- Type 2 diabetes
- Cardiovascular disease
- Cancer
- Dying earlier than expected
Some reporting on the study has also pointed to signs of a healthier metabolic profile among carriers, including lower cholesterol and healthier liver function, though the researchers are cautious about how far to take this.
Their main message is narrower and more careful: this particular, lifelong form of insulin resistance did not carry the health costs that insulin resistance usually carries.
What This Means for Obesity, Diabetes, and Metabolic Health
For most people, insulin resistance shows up alongside extra body fat — especially the fat that builds up around your organs, called visceral fat.
That kind of insulin resistance really is linked to a higher risk of type 2 diabetes, heart disease, and other problems. Nothing in this new study changes that.
What the study adds is a new question: is insulin resistance itself the direct cause of that damage? Or is insulin resistance often just a marker that shows up alongside the real troublemakers, like excess visceral fat, chronic inflammation, and an overloaded liver?
The Exeter team’s carriers had insulin resistance without those other things going on. And their health looked fine.
That’s a clue — not proof — that insulin resistance by itself might not be the dangerous part. It might be more like a smoke detector going off because of a fire somewhere else in the house, rather than being the fire itself.
This lines up with decades of research in worms, flies, and mice, which has repeatedly found that dialing down insulin and a related hormone pathway (called IGF-1 signaling) can sometimes extend lifespan and improve health in old age.
That research is a separate line of evidence, done in animals rather than people, but it points in a similar direction: reduced insulin signaling isn’t automatically bad for the body. In some contexts, animal studies have found it can even be protective.
It’s worth being careful here, though. Other animal studies have found the opposite — cutting insulin signaling in certain tissues or at certain stages of life shortened lifespan instead of extending it.
So the honest summary is that the relationship between insulin resistance and long-term health is not a straight line. It depends heavily on which tissues are affected, at what age, and for what underlying reason.
Practical Implications
Because this is early, unpublished research about a rare genetic condition, it doesn’t translate into a specific action plan for most readers.
Nobody should try to lower their own insulin sensitivity on purpose, and nothing about this study suggests that’s a good idea.
The most useful takeaway is a shift in mindset rather than a to-do list: insulin resistance detected on a lab test is a signal worth paying attention to, but it’s not automatically a life sentence, and it doesn’t mean the same thing for every single person.
Your doctor will always look at insulin resistance together with your weight, your blood sugar trends, your family history, and your overall metabolic picture — not as a standalone red flag.
What We Know
- Insulin resistance that develops alongside excess body fat, especially visceral fat, is strongly and consistently linked to a higher risk of type 2 diabetes and heart disease.
- A rare, lifelong, genetic form of insulin resistance — caused by a damaged INSR gene — was linked to mild hyperinsulinemia but not to higher rates of diabetes, heart disease, cancer, or early death in this study.
- Animal research going back decades has shown that reduced insulin and IGF-1 signaling can extend healthy lifespan in worms, flies, and some mouse models, though the effect is smaller and less consistent in mammals than in simpler organisms.
What We Don’t Know
- Whether these findings will hold up once the full study is peer-reviewed and published.
- Whether the results would look the same in larger, more diverse populations — the study so far has focused on people of European ancestry.
- Exactly why this genetic form of insulin resistance seems to behave differently in the body than the more common, obesity-linked form.
- Whether there’s anything about this discovery that could eventually be turned into new treatments or protective strategies — the researchers describe this as a future research direction, not a current possibility.
Common Misconceptions
“Insulin resistance always means you’re on the path to diabetes.”
Not necessarily. This study suggests the source and pattern of insulin resistance matter, not just the presence of it. Most real-world insulin resistance, tied to excess weight, does raise diabetes risk. But it isn’t automatically true in every case.
“If insulin resistance can be harmless, I don’t need to worry about mine.”
That would be the wrong lesson to take from this study. The people studied have a specific, rare genetic pattern that is different from the insulin resistance most people develop over time.
If your doctor has flagged insulin resistance or prediabetes, that assessment is based on your actual risk factors, not on a rare genetic exception.
“Scientists have proven insulin resistance is actually good for you.”
No study has shown that. The researchers themselves describe this as an early, cautious finding that raises new questions — not a green light to view insulin resistance as beneficial.
Who Should Be Particularly Concerned
This study is not really about individual risk, since it describes a rare genetic pattern that most people don’t have. The people who should still pay close attention to insulin resistance in the ordinary sense include:
- Adults with excess weight, especially extra fat around the waist and abdomen
- People with a parent or sibling who has type 2 diabetes
- People with high blood pressure, high triglycerides, or low “good” cholesterol (HDL)
- People who are told by a doctor they have prediabetes or elevated fasting insulin
- Certain racial and ethnic groups with a higher background risk of type 2 diabetes, including African American, Hispanic/Latino, American Indian, Alaska Native, Asian American, and Pacific Islander communities
For these groups, this new research is interesting background, not a reason to change anything about screening or care.
Practical, Evidence-Based Recommendations
- Keep up with the screening your doctor recommends, including blood sugar and insulin-related tests if you’re in a higher-risk group.
- Focus on the factors with the strongest, most consistent evidence behind them: maintaining a healthy weight, staying physically active, eating a diet with plenty of fiber and whole foods, and getting enough sleep.
- Don’t use this study as a reason to ignore a prediabetes or insulin resistance diagnosis. The exception described here is rare and different from typical, obesity-linked insulin resistance.
- If you’re curious about your own results, talk to your doctor about what your specific numbers mean for you, rather than trying to interpret a single test in isolation.
FAQ
Is insulin resistance always bad?
Usually, yes, especially when it develops alongside excess weight. This study shows a rare exception, not a new rule.
What is the INSR gene?
INSR carries the instructions for building the insulin receptor, the part of a cell that insulin attaches to in order to deliver its message.
Is this study published yet?
Not fully. It will be presented at a major diabetes research conference in Milan at the end of September 2026, but it hasn’t yet gone through peer review and journal publication.
Should I try to lower my insulin sensitivity?
No. Nothing in this research suggests trying to become more insulin resistant is safe or helpful. The people studied have a rare, lifelong genetic pattern, not something that can or should be replicated on purpose.
Does this mean weight loss doesn’t matter for insulin resistance?
No. For the overwhelming majority of people, insulin resistance is tied to excess weight, and losing weight remains one of the most effective ways to improve it.
Conclusion
Insulin resistance has a well-earned reputation as a warning sign. This new research doesn’t erase that reputation, but it does add nuance: at least in one rare, genetic case, insulin resistance showed up without the health problems usually attached to it.
That’s a hint that insulin resistance itself might not be the direct cause of disease so much as a marker that often travels alongside the real risk factors, like excess visceral fat and chronic inflammation.
For now, the practical guidance hasn’t changed. If you or your doctor are watching your insulin resistance, keep doing that. But it’s a good reminder that the body’s metabolic story is rarely as simple as one number on a lab report.
References
1. Murray Leech, J., Patel, K., et al. Insulin resistance tied to rare genetic variants may confer healthier metabolic profile. Findings to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), Milan, Italy, September 28–October 2, 2026. Reported via Healio Endocrinology [Ref]
2. Irish Medical Times. “Not all insulin resistance bad for health, study suggests.” August 18, 2026.
3. American Diabetes Association. Standards of Care in Diabetes — 2026: Diagnosis and Classification of Diabetes. Diabetes Care.
4. National Diabetes Information Clearinghouse. Insulin Resistance and Prediabetes.
5. Frontiers in Endocrinology. “Insulin and aging – a disappointing relationship.” 2023.
6. Distinct, common and synergistic effects of insulin and IGF-1 receptors on healthy murine ageing (model-organism research on insulin/IGF-1 signaling and lifespan).
7. Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan (mouse model research showing mixed effects of reduced insulin signaling).
